-
2
-
-
0035144143
-
Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate
-
Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305–309.
-
(2001)
Fertil Steril
, vol.75
, pp. 305-309
-
-
Mitwally, M.F.1
Casper, R.F.2
-
3
-
-
0025030576
-
Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth
-
Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990; 5:670–674.
-
(1990)
Hum Reprod
, vol.5
, pp. 670-674
-
-
Gonen, Y.1
Casper, R.F.2
-
4
-
-
0026052238
-
Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles
-
Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril. 1991;56:465–468.
-
(1991)
Fertil Steril
, vol.56
, pp. 465-468
-
-
Randall, J.M.1
Templeton, A.2
-
5
-
-
1942486391
-
Aromatase inhibitors in ovulation induction
-
Mitwally MF, Casper RF. Aromatase inhibitors in ovulation induction. Semin Reprod Med. 2004;22:61–78.
-
(2004)
Semin Reprod Med
, vol.22
, pp. 61-78
-
-
Mitwally, M.F.1
Casper, R.F.2
-
6
-
-
84870373365
-
Historical perspective of aromatase inhibitors for ovulation induction
-
Casper RF, Mohamed FM. Historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril. 2012;98:1352–1355
-
(2012)
Fertil Steril
, vol.98
, pp. 1352-1355
-
-
Casper, R.F.1
Mohamed, F.M.2
-
7
-
-
40749085240
-
Consensus on infertility treatment related to polycystic ovary syndrome
-
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
-
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008;23:462–477
-
(2008)
Hum Reprod
, vol.23
, pp. 462-477
-
-
-
8
-
-
0018847979
-
The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease
-
Wang CF, Gemzell C. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertil Steril. 1980;33:479–486
-
(1980)
Fertil Steril
, vol.33
, pp. 479-486
-
-
Wang, C.F.1
Gemzell, C.2
-
9
-
-
0025996189
-
Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovarian syndrome
-
Hamilton-Fairley D, Kiddy D, Watson H, Sagle M, Franks S. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovarian syndrome. Hum Reprod. 1991;6:1095–1099
-
(1991)
Hum Reprod
, vol.6
, pp. 1095-1099
-
-
Hamilton-Fairley, D.1
Kiddy, D.2
Watson, H.3
Sagle, M.4
Franks, S.5
-
11
-
-
0030724827
-
Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: Prospective, randomized comparison between low dose step-up and step-down dose regimens
-
van Santbrink EJ, Fauser BC. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab. 1997;82: 3597–3602
-
(1997)
J Clin Endocrinol Metab
, vol.82
, pp. 3597-3602
-
-
Van Santbrink, E.J.1
Fauser, B.C.2
-
12
-
-
0027410538
-
Overstimulated cycles under low-dose gonadotrophins in patients with polycystic ovary syndrome: Characterization and management
-
Herman A, Ron-El R, Golan A, Soffer Y, Bukovsky I, Caspi E. Overstimulated cycles under low-dose gonadotrophins in patients with polycystic ovary syndrome: characterization and management. Hum Reprod. 1993;8:30–34
-
(1993)
Hum Reprod
, vol.8
, pp. 30-34
-
-
Herman, A.1
Ron-El, R.2
Golan, A.3
Soffer, Y.4
Bukovsky, I.5
Caspi, E.6
-
13
-
-
84890561877
-
Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: Randomized controlled trial
-
Ghanem ME, Elboghdady LA, Hassan M, et al. Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial. J Assist Reprod Genet. 2013;30:1477–1485
-
(2013)
J Assist Reprod Genet
, vol.30
, pp. 1477-1485
-
-
Ghanem, M.E.1
Elboghdady, L.A.2
Hassan, M.3
-
14
-
-
84890567954
-
Comment on: “Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: Randomized controlled trial.” by Ghanem et al
-
Papathanasiou A. Comment on: “Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.” by Ghanem et al. J Assist Reprod Genet. 2013;30:1525
-
(2013)
J Assist Reprod Genet
, vol.30
, pp. 1525
-
-
Papathanasiou, A.1
-
15
-
-
0348231002
-
Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination
-
Healey S, Tan SL, Tulandi T, Biljan MM. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril. 2003;80:1325–1329
-
(2003)
Fertil Steril
, vol.80
, pp. 1325-1329
-
-
Healey, S.1
Tan, S.L.2
Tulandi, T.3
Biljan, M.M.4
-
16
-
-
0041488805
-
Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility
-
Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum Reprod. 2003;18:1588–1597
-
(2003)
Hum Reprod
, vol.18
, pp. 1588-1597
-
-
Mitwally, M.F.1
Casper, R.F.2
-
17
-
-
77949515078
-
Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome
-
Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop Group
-
Rotterdam ESHRE/ASRM–Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term healthy risks related to polycystic ovary syndrome. Fertil Steril. 2004;82:1193–1197
-
(2004)
Fertil Steril
, vol.82
, pp. 1193-1197
-
-
-
18
-
-
0031056712
-
Manipulation of human ovarian function: Physiological concepts and clinical consequences
-
Fauser BC, Van Huesden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endrocr Rev. 1997;18:71–106
-
(1997)
Endrocr Rev
, vol.18
, pp. 71-106
-
-
Fauser, B.C.1
Van Huesden, A.M.2
-
20
-
-
0035081340
-
Polycystic ovary syndrome and ovulation induction
-
Phipps WR. Polycystic ovary syndrome and ovulation induction. Obstet Gynecol Clin North Am. 2001;28:165–182
-
(2001)
Obstet Gynecol Clin North Am
, vol.28
, pp. 165-182
-
-
Phipps, W.R.1
-
21
-
-
0031882643
-
Recombinant folliclestimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate–resistant, normogonadotropic, chronic anovulation: A prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group
-
Coelingh Bennink HJ, Fauser BC, Out HJ. Recombinant folliclestimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate–resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Fertil Steril. 1998;69:19–25
-
(1998)
Fertil Steril
, vol.69
, pp. 19-25
-
-
Coelingh Bennink, H.J.1
Fauser, B.C.2
Out, H.J.3
-
22
-
-
0035073952
-
Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: Prospective, randomized comparison between low-dose step-up and modified step-down regimens
-
Balasch J, Fábregues F, Creus M, Puerto B, Peñarrubia J, Vanrell JA. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Hum Reprod. 2001;16:652–656
-
(2001)
Hum Reprod
, vol.16
, pp. 652-656
-
-
Balasch, J.1
Fábregues, F.2
Creus, M.3
Puerto, B.4
Peñarrubia, J.5
Vanrell, J.A.6
-
23
-
-
0033180070
-
Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate–resistant, normogonadotropic, chronic anovulation: A prospective randomized study
-
Yarali H, Bukulmez O, Gurgan T. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate–resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil Steril. 1999;72:276–281
-
(1999)
Fertil Steril
, vol.72
, pp. 276-281
-
-
Yarali, H.1
Bukulmez, O.2
Gurgan, T.3
-
24
-
-
0030482132
-
Sequential step-up and step-down dose regimen: An alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome
-
Hugues JN, Cedrin-Durnerin I, Avril C, Bulwa S, Herve F, Uzan M. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome. Hum Reprod. 1996;11:2581–2584
-
(1996)
Hum Reprod
, vol.11
, pp. 2581-2584
-
-
Hugues, J.N.1
Cedrin-Durnerin, I.2
Avril, C.3
Bulwa, S.4
Herve, F.5
Uzan, M.6
-
25
-
-
80055068439
-
Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome
-
Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome. Clin Obstet Gynecol. 2011;54:685–695
-
(2011)
Clin Obstet Gynecol
, vol.54
, pp. 685-695
-
-
Casper, R.F.1
Mitwally, M.F.2
-
26
-
-
0030662215
-
Absolute bioavailability of letrozole in healthy post-menopausal women
-
Sioufi A, Gauducheau N, Pineau V, et al. Absolute bioavailability of letrozole in healthy post-menopausal women. Biopharm Drug Dispos. 1997;18:779–789
-
(1997)
Biopharm Drug Dispos
, vol.18
, pp. 779-789
-
-
Sioufi, A.1
Gauducheau, N.2
Pineau, V.3
-
27
-
-
0030758005
-
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration
-
Sioufi A, Sandrenan N, Godbillon J, et al. Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administration. Biopharm Drug Dispos. 1997;18: 489–497
-
(1997)
Biopharm Drug Dispos
, vol.18
, pp. 489-497
-
-
Sioufi, A.1
Sandrenan, N.2
Godbillon, J.3
-
28
-
-
0028277778
-
Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: A prospective, randomized trial
-
MacDougall MJ, Tan SL, Hall V, Balen A, Mason BA, Jacobs HS. Comparison of natural with clomiphene citrate-stimulated cycles in in vitro fertilization: a prospective, randomized trial. Fertil Steril. 1994;61:1052–1057
-
(1994)
Fertil Steril
, vol.61
, pp. 1052-1057
-
-
Macdougall, M.J.1
Tan, S.L.2
Hall, V.3
Balen, A.4
Mason, B.A.5
Jacobs, H.S.6
-
29
-
-
70349441047
-
Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: A prospective randomized trial
-
Badawy A, Elnashar A, Totongy M. Clomiphene citrate or aromatase inhibitors for superovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized trial. Fertil Steril. 2009;92:1355–1359
-
(2009)
Fertil Steril
, vol.92
, pp. 1355-1359
-
-
Badawy, A.1
Elnashar, A.2
Totongy, M.3
-
30
-
-
0032742006
-
Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon)
-
Buckler HM, Robertson WR, Anderson A, Vickers M, Lambert A. Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon). Hum Reprod. 1999;14:2969–2973
-
(1999)
Hum Reprod
, vol.14
, pp. 2969-2973
-
-
Buckler, H.M.1
Robertson, W.R.2
Erson, A.3
Vickers, M.4
Lambert, A.5
-
31
-
-
0034500488
-
Recombinant human follicle-stimulating homrone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol
-
Balasch J, Fábregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA. Recombinant human follicle-stimulating homrone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. J Assist Reprod Genet. 2000;1:561–565
-
(2000)
J Assist Reprod Genet
, vol.1
, pp. 561-565
-
-
Balasch, J.1
Fábregues, F.2
Creus, M.3
Casamitjana, R.4
Puerto, B.5
Vanrell, J.A.6
-
32
-
-
0031759990
-
A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women
-
Hedon B, Hugues JN, Emperaire JC, et al. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod. 1998;13:2688–2692
-
(1998)
Hum Reprod
, vol.13
, pp. 2688-2692
-
-
Hedon, B.1
Hugues, J.N.2
Emperaire, J.C.3
-
33
-
-
0042624699
-
A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome
-
Recombinant FSH Study Group
-
Christin-Maitre S, Hugues JN; Recombinant FSH Study Group. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod. 2003;18:1626–1631.
-
(2003)
Hum Reprod
, vol.18
, pp. 1626-1631
-
-
Christin-Maitre, S.1
Hugues, J.N.2
|